Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 21-40 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 21 | GalaxEye mediummedium | Opp 7 Risk 4 | Thesis: GalaxEye has the clearest opportunity evidence in the screen because it moved from pre-launch to an actual in-orbit milestone for Mission Drishti, described as the first OptoSAR satellite, and also has evidence of a commercialization path via an NSIL data-resale arrangement. For a 1 year+ horizon, a successful first satellite launch can support follow-on constellation buildout, data sales, and fundraising progression if commissioning and execution continue. Why now: The key timing change is that earlier pre-launch coverage from April 23, 2026 was followed by launch coverage on May 3, 2026/May 4, 2026, and later June 16, 2026 context states the first satellite was launched in May 2026, confirming a business-state transition from concept/pre-launch to deployed asset status. The NSIL resale agreement was reported earlier on February 13, 2026, giving a potential go-to-market bridge once satellite data is available. Evidence
Caveats: Most reviewed sources rows are neutral facts or supporting article context rather than explicit positive evidence. Funding totals vary across articles (~$14.5M, $18.3M, ~$20M), so exact capitalization is uncertain |
| 22 | Loft Orbital mediummedium | Opp 7 Risk 3 | Thesis: Loft Orbital has the strongest opportunity case in this screen because multiple dated within the recent evidence window articles describe a multi-year CNES contract worth up to tens of millions of euros for a next-generation Earth observation constellation, with the first satellite scheduled for Q4 2026 or by year-end 2026. Additional 2026 context says Loft is expanding from hosted payloads into full-service 'constellations as a service,' which supports a durable 1 year+ strategic scaling thesis. Why now: Why now is credible for a 1 year+ horizon because several dated articles from 2026 establish a recent contract win and near-forward deployment timeline: Loft announced on April 30, 2026 a multi-year CNES contract worth up to tens of millions of euros with first satellite scheduled to launch in Q4 2026. Via Satellite on May 1, 2026 described a 10-satellite EO constellation under that contract. SpaceNews on May 5, 2026 said Loft is expanding into 'full-service constellation deals'. Evidence
Caveats: Most retained support is supporting article context, which the reviewed sources treats as bounded context and weaker than direct dated event/fact evidence. Several favorable funding articles for Loft are dated January 2025 and were dropped by the 90-day recent evidence window, so they should not drive the current score. Execution risk remains around deploying the constellation and meeting the stated 2026 launch timing. |
| 23 | Momentus mediummedium | Opp 7 Risk 5 | Thesis: Momentus has credible 1 year+ opportunity from recent execution milestones and commercial/government traction: Vigoride 7 launched in late March 2026, and in June 2026 the company announced a new commercial contract for Vigoride-9 in-orbit services. This supports product progression from demonstration toward revenue-bearing missions. Why now: Why-now is supported by recent mission and contract evidence within the recent evidence window: on March 30, 2026 Momentus announced the successful launch of Vigoride 7 and called it its most advanced on-orbit demonstration campaign to date; on June 17, 2026 it announced a new commercial contract with LASP to host and operate the OWLS mission on Vigoride-9, expanding its commercial revenue portfolio. Evidence
Caveats: The SHIELD contract-vehicle selection is dated December 10, 2025 and outside the 90-day recent evidence window, so it is useful background but not a recency catalyst here. Some weak context rows repeat the same article-level claims and are not independent confirmation. |
| 24 | Open Cosmos mediummedium | Opp 7 Risk 3 | Thesis: Open Cosmos has the clearest visible operating-progress evidence in the screen. A June 17, 2026 article says it launched the first two satellites of its new Ka-band LEO telecom constellation and had secured a license from Liechtenstein a week earlier to use high-priority radio bands, indicating actual network rollout and regulatory progress toward sovereign and secure communications offerings for governments and enterprises. Why now: The timing is favorable for a 1 year+ horizon because the latest dated evidence on June 17, 2026 indicates market entry and operation of the first telecom satellites, which can matter over a multi-quarter rollout period. A prior April 8, 2026 article also shows Open Cosmos spacecraft being used in the Orpheus UK military mission, adding defense-adjacent relevance. These dates are source dates extracted from the article summaries. Evidence
Caveats: Evidence is external article context and weak-context rows, not direct positive events. Same-article repeated rows are not independent confirmation. |
| 25 | Rocket Lab USA, Inc. highstrong | Opp 7 Risk 4 | Thesis: Rocket Lab has credible long-horizon opportunity from expanding beyond launch into higher-value national security satellite production and operations, while also showing continued commercial launch execution. Why now: The main catalyst is the May 2026 award of Rocket Lab's first GEO satellite production program for the U.S. Space Force, which extends the company into a new orbital regime and broadens its mission model. That is paired with evidence of ongoing launch execution on May 22, 2026 through the ninth dedicated Electron mission for Synspective. Evidence
Caveats: The reviewed sources contain no direct negative events, so risk is mainly execution-based rather than explicitly evidenced adverse news. One representative item references stock performance but is undated and should not be treated as reliable recency proof. |
| 26 | Sateliot mediummedium | Opp 7 Risk 5 | Thesis: Sateliot has a solid 1 year+ opportunity setup because company-linked facts say it launched a €100 million Series C round to deploy 16 satellites for 5G IoT and direct-to-device connectivity, while later article context adds that it signed its first commercial contract for a dedicated LEO launch for two Tritó satellites in 2027. The combination of financing and launch planning supports constellation build-out potential. Why now: The sequence matters: the company launched the Series C on April 8, 2026/April 13, 2026, then later reporting on May 21, 2026 noted a first commercial launch contract, and June 24, 2026 reporting still described the round as seeking capital and a lead investor. That mix creates both opportunity and financing risk over a 1 year+ horizon. Evidence
Caveats: The reviewed sources does not provide a direct positive event row for the first commercial contract; that support is supporting article context and weaker than a structured company event row. Later dated coverage indicates financing is still being sought, which partially offsets the opportunity thesis. Undated context items exist in the reviewed sources but are not used for recency-sensitive judgments. |
| 27 | SatSure mediummedium | Opp 7 Risk 4 | Thesis: SatSure has the strongest non-Boeing opportunity setup in this screen because multiple recent article summaries indicate it secured a 246 million rupee ($2.57 million) grant from India's space regulator to develop AI-powered Earth observation models, and a later June 2026 article says Safran Electronics & Defense and SatSure signed an MoU to collaborate on GEOINT solutions for the Indian market. Together these suggest both public-sector support and ecosystem partnership momentum relevant over a 1 year+ horizon Why now: Why now is strong because the June 11-22, 2026 evidence sequence shows fresh capital support first, then a later strategic partnership, suggesting opportunity maturation within weeks rather than stale background context Evidence
Caveats: Most evidence is supporting article context or weak context rather than direct positive events. Same-story repetition around the grant should not be treated as independent confirmation. No direct available evidence of revenue, backlog conversion, or deployment milestones. |
| 28 | Starfish Space mediumstrong | Opp 7 Risk 3 | Thesis: Starfish Space has the strongest positive evidence in the screen: recent Series B funding of more than $100 million and company-linked evidence of existing work with Space Force, NASA, and SES support a multi-year scaling thesis in on-orbit servicing. Why now: The timing is favorable for a 1 year+ horizon because recent financing on April 7, 2026 was explicitly tied to executing first servicing missions and boosting production, following prior government contract momentum Evidence
Caveats: The strongest support is external web-search evidence, though it is company-linked and dated. Some contract details in weaker article context vary and should not be over-aggregated across repeated articles. |
| 29 | TakeMe2Space mediummedium | Opp 7 Risk 3 | Thesis: TakeMe2Space has recent funding support from IN-SPACe under the Technology Adoption Fund, with the article stating selected startups will each receive up to ₹25 crore, which supports a durable financing-and-development opportunity over a 1 year+ horizon. Why now: The IN-SPACe funding article is dated June 12, 2026, very recent within the recent evidence window, and describes first investment into selected Indian spacetech startups including TakeMe2Space, which could shape the next year of development. Source date: June 12, 2026 Evidence
Caveats: Reviewed evidence notes prior broader membership support, but only one in-window article context is retained here. Evidence is supporting article context only despite stronger historical support counts. |
| 30 | Turion Space mediummedium | Opp 7 Risk 5 | Thesis: Turion Space has credible long-horizon opportunity because the reviewed sources show a sizable Series B closed on April 15, 2026 to accelerate deployment of its space domain awareness satellite fleet, alongside evidence that it has already launched spacecraft and is expanding a maneuverable satellite fleet for in-orbit observation missions. Why now: The key timing driver is the dated financing round on April 15, 2026, which the reviewed sources say positions the company to scale beyond single-mission spacecraft toward a persistent SDA constellation, a development relevant over a 1 year+ horizon. Evidence
Caveats: The reviewed sources have no direct positive or negative dated events; the case relies on supporting article context rather than stronger internal company-specific events. The company website context on May 23, 2026 is weaker than independent company-specific event evidence and should not be overweighted. Citation |
| 31 | Astrobase Space Technologies mediummedium | Opp 6 Risk 4 | Thesis: Astrobase has visible funding support tied to a specific propulsion-development goal. A June 12, 2026 article says IN-SPACe selected it under the Technology Adoption Fund and that each project can receive up to ₹25 crore; the same summary says Astrobase aims to develop a high-thrust closed-cycle liquid rocket engine. For a 1 year+ horizon, non-dilutive or quasi-public funding for propulsion development is a meaningful opportunity signal. Why now: The funding article is recent, with published June 12, 2026, and specifically notes this as IN-SPACe's first investment in Indian startups under the TAF scheme. That timing matters for a 1 year+ horizon because it may enable development progress over coming quarters. Evidence
Caveats: Visible evidence is only one external article summary despite the membership rationale referencing multiple structured support articles. No technical test results or customer contracts are provided in the exposed evidence. |
| 32 | Blue Origin mediummedium | Opp 6 Risk 7 | Thesis: Blue Origin has meaningful long-horizon upside from multiple recent demand signals: a Space Force national security launch task order, a planned return-to-service New Glenn launch for 48 Amazon Leo satellites, and a NASA moon-base award tied to a fall 2026 target window. Why now: The setup is active and recent: on May 30, 2026 SpaceNews reported Blue Origin received an NSSL task order hours before a New Glenn explosion, while on May 27, 2026 GeekWire reported New Glenn was preparing to return to service for an Amazon Leo mission after its first launch failure; on May 26, 2026 Investing.com summarized a NASA moon-base contract with launch no earlier than fall 2026 Evidence
Caveats: Positive evidence is mostly supporting article context rather than direct events. One external article is undated and is not relied on for recency proof. Government support after the anomaly partially offsets, but does not erase, execution risk. |
| 33 | ElevationSpace mediummedium | Opp 6 Risk 2 | Thesis: ElevationSpace has one of the better opportunity setups in this screen because the reviewed sources includes a recent dated article saying it raised $40 million in Series B funding, bringing total raised to $63.5 million, for a business developing space-to-Earth transportation and a space environment utilization and recovery platform. A large recent financing can support product development and scaling over a 1 year+ horizon. Why now: The catalyst is recent and dated: the financing article is timestamped June 19, 2026, which is inside the 90-day recent evidence window and recent enough to matter for a 1 year+ business-building horizon. Evidence
Caveats: Support is still supporting article context rather than direct positive events. Only one article is available, limiting corroboration. |
| 34 | General Atomics mediummedium | Opp 6 Risk 2 | Thesis: General Atomics has the clearest opportunity signal in the screen because an article dated April 8, 2026 says Space Systems Command awarded 14 companies more than $1.8 billion in Andromeda contracts for the Geosynchronous Reconnaissance & Surveillance Constellation, and General Atomics is named among the companies. For a 1 year+ horizon, inclusion in a large U.S. defense-space procurement could support durable program participation if it converts into funded work streams, though the reviewed sources only provides supporting article context rather than a direct company event row., April 8, 2026 Why now: The catalyst is recent within the reviewed sources recent evidence window: the is April 8, 2026, and it describes Space Force awarding Andromeda contracts, a potentially durable procurement cycle relevant to a 1 year+ horizon., April 8, 2026 Evidence
Caveats: This is supporting article context/weak context, not a direct company event row. Same-article repeated rows in the reviewed sources are not independent confirmation. |
| 35 | GITAI mediummedium | Opp 6 Risk 3 | Thesis: GITAI has the strongest opportunity setup in this screen because a dated June 16, 2026 company announcement says it completed the flight model of its S3 robotic satellite mission for an on-orbit servicing technology demonstration and framed the platform as supporting future defense-focused LEO constellation services, indicating tangible program maturation rather than just category membership. Why now: The key catalyst is recent and inside recent evidence window: on June 16, 2026, GITAI announced completion of the S3 flight model for an on-orbit servicing demonstration mission, which is directly relevant to a 1 year+ horizon because it may precede launch, demonstration, and downstream defense/commercial adoption over the next year. Evidence
Caveats: Primary evidence is from the company itself. No retained independent customer, contract, or revenue evidence is provided. The spaceindex.io entry is undated and should not be treated as recency proof. |
| 36 | Intuitive Machines, Inc. mediummedium | Opp 6 Risk 5 | Thesis: Intuitive Machines has moderate long-horizon opportunity because recent Space Force selection expands its relevance beyond lunar services into space surveillance capabilities, potentially broadening its addressable defense business. Why now: The timing case comes from May 12, 2026 reporting that Intuitive Machines was selected for the Space Force Andromeda IDIQ to develop space surveillance capabilities through 2030 and beyond, described as the company's first major selection following the Lanteris Space acquisition. Evidence
Caveats: The reviewed sources provide supporting article context but no direct structured fact with quantified contract value specific to Intuitive Machines. No direct adverse evidence is available; risk is based on competitive award structure and evidence limitations. Long-horizon upside depends on conversion from selection status into meaningful programs. |
| 37 | Kepler mediummedium | Opp 6 Risk 3 | Thesis: Kepler shows a meaningful operational milestone: the company said it successfully launched the first tranche of optical relay satellites and that a 10-satellite ring marks the beginning of its operational optical data relay network. For a 1 year+ horizon, first-network deployment can support follow-on service activation and adoption. Why now: The latest visible evidence is dated June 23, 2026, making the milestone recent within the 90-day recent evidence window. The article explicitly frames this as the beginning of an operational network, which is more relevant to a 1 year+ horizon than a short-lived announcement. Evidence
Caveats: Primary evidence is from Kepler's own site. No direct contract, revenue, or financing detail is provided in the visible evidence. Same article appears in both representative and weak-context forms, which is not independent confirmation. |
| 38 | L3Harris Technologies mediummedium | Opp 6 Risk 3 | Thesis: L3Harris has a moderate opportunity case from current participation in the Space Force’s Andromeda space domain awareness effort, which could support multi-year defense-space positioning. Recent article context published April 8, 2026 lists L3Harris among the companies awarded Andromeda contracts for RG-XX satellites. Why now: The recent timing anchor is the April 8, 2026 Andromeda article. Older 2020 MOSSAIC history exists in the reviewed sources but should not drive the current timing view because it is outside the recent evidence window and materially older than the current contract context. Evidence
Caveats: Current opportunity case depends on supporting article context rather than available direct positive events. The reviewed sources includes an older 2020 contract article, but that is not recent support for 'why now'. |
| 39 | Lockheed Martin mediummedium | Opp 6 Risk 2 | Thesis: Recent supporting article context indicates Lockheed Martin won a Space Force contract worth up to $105 million to modernize the GPS ground control network and support GPS IIIF operations, which supports a durable government-space revenue opportunity over a 1 year+ horizon. Why now: The relevant contract article is dated April 16, 2026, inside the 90-day recent evidence window, and describes current modernization work tied to GPS IIIF support, which can matter over a multi-quarter horizon. Source date: April 16, 2026 Evidence
Caveats: Evidence is supporting article context only; no direct positive event row is available. Same article appears in multiple weak-context rows and does not count as independent confirmation. |
| 40 | Logos Space Services mediummedium | Opp 6 Risk 4 | Thesis: Among this screen, Logos has the clearest in-recent evidence window strategic progress: it recently secured FCC approval for a very large broadband constellation of up to 4,178 satellites, which is a meaningful regulatory milestone for a long-horizon satellite communications buildout. Why now: A dated article within the 90-day recent evidence window, with based on April 13, 2026, states that Logos Space Services recently secured FCC approval for a constellation of up to 4,178 broadband satellites and described both target customers and technical architecture, making this a timely strategic-development signal for a 1 year+ horizon. Evidence
Caveats: Evidence is supporting article context, not a richer set of direct dated events/facts. Only one article after recent evidence window; same-article repeated rows are not independent confirmation. |
Risk view
Showing rows 81-100 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 81 | Interlune lowweak | Opp 5 Risk 3 | Thesis: The company also carries execution risk because the reviewed sources provide no further retained evidence on milestone completion, follow-on awards, commercialization timing, or technical results. A single contract supports relevance but does not prove scalable economics. Why now: The key 'why now' is the cited NASA contract in article: but the reviewed sources does not include the article summary or, so exact date and latest status are not visible here. Caveats: Opportunity case relies on membership rationale rather than included direct article evidence. A $6.9M contract is positive validation, but contract size alone may not be enough to de-risk a lunar-resource business. No negative evidence is provided, so risk mostly reflects execution uncertainty. |
| 82 | IonQ lowweak | Opp 3 Risk 3 | Thesis: Risk stems from thesis leakage: the reviewed sources frames IonQ primarily as parent/acquirer, while the strongest space-specific evidence appears to sit at subsidiary level, so investors could overstate IonQ's direct space-business impact based on insufficient company-specific proof. Why now: Potential 'why now' would be the referenced space-subsidiary contract pathway, but recency and direct materiality to IonQ are not validated in available evidence for the 90-day recent evidence window. Caveats: Phase-2 rationale references and: but no or summaries are provided in the reviewed sources. Relations and counterparty propagation are not allowed by default. Coverage debug shows zero evidence after recent evidence window despite a large article universe. |
| 83 | Iridium Communications Inc. lowmedium | Opp 5 Risk 3 | Thesis: Risk is moderate-low because there is no direct adverse evidence, but the reviewed sources lack recent company-specific contract, financing, or product milestone catalysts, so the case depends more on strategic position than on fresh business acceleration. Why now: The current support is an April 3, 2026 article-level overview of Iridium’s constellation and service footprint rather than a new event, so timing fit is only medium. Evidence
Caveats: Evidence is supporting article context, not a fresh contract or earnings-linked milestone. |
| 84 | Kepler mediummedium | Opp 6 Risk 3 | Thesis: Risk remains moderate because the evidence is primarily a company-source article and supporting article context rather than independent dated event evidence. The reviewed sources show no adverse developments, but also limited third-party confirmation. Why now: The latest visible evidence is dated June 23, 2026, making the milestone recent within the 90-day recent evidence window. The article explicitly frames this as the beginning of an operational network, which is more relevant to a 1 year+ horizon than a short-lived announcement. Evidence
Caveats: Primary evidence is from Kepler's own site. No direct contract, revenue, or financing detail is provided in the visible evidence. Same article appears in both representative and weak-context forms, which is not independent confirmation. |
| 85 | Kepler Aerospace lowweak | Opp 3 Risk 3 | Thesis: There is no direct negative evidence available. The main risk is that the business description is broad but unsupported by current, citable post-recent evidence window evidence, leaving commercialization and scale uncertain. Why now: No current catalyst is established. Membership support references article ID: but the reviewed sources provide no and shows no evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Context includes relation/fact counts in support statistics, but relations are context-only and cannot be propagated as operating proof. |
| 86 | L3Harris Technologies mediummedium | Opp 6 Risk 3 | Thesis: Risk is lower than many peers in these reviewed sources because there is no cited direct adverse evidence, but the ranking is capped by limited fresh company-specific evidence within the 90-day window and reliance on supporting article context rather than detailed award economics attributable specifically to L3Harris. Why now: The recent timing anchor is the April 8, 2026 Andromeda article. Older 2020 MOSSAIC history exists in the reviewed sources but should not drive the current timing view because it is outside the recent evidence window and materially older than the current contract context. Evidence
Caveats: Current opportunity case depends on supporting article context rather than available direct positive events. The reviewed sources includes an older 2020 contract article, but that is not recent support for 'why now'. |
| 87 | Loft Orbital mediummedium | Opp 7 Risk 3 | Thesis: Risk exists because the positive case is largely supporting article context from external supporting source sources rather than direct dated events in the reviewed sources, and execution remains significant given a 10-satellite constellation deployment and launch timeline. But there is no retained material adverse evidence. Why now: Why now is credible for a 1 year+ horizon because several dated articles from 2026 establish a recent contract win and near-forward deployment timeline: Loft announced on April 30, 2026 a multi-year CNES contract worth up to tens of millions of euros with first satellite scheduled to launch in Q4 2026. Via Satellite on May 1, 2026 described a 10-satellite EO constellation under that contract. SpaceNews on May 5, 2026 said Loft is expanding into 'full-service constellation deals'. Evidence
Caveats: Most retained support is supporting article context, which the reviewed sources treats as bounded context and weaker than direct dated event/fact evidence. Several favorable funding articles for Loft are dated January 2025 and were dropped by the 90-day recent evidence window, so they should not drive the current score. Execution risk remains around deploying the constellation and meeting the stated 2026 launch timing. |
| 88 | MDA Space Ltd. lowweak | Opp 4 Risk 3 | Thesis: Risk is moderate because the available evidence is entirely undated external article context, making recency and state-of-business uncertain. Why now: Why-now is weak because both available representative articles are undated, so current timing and whether these items remain incremental versus already absorbed is uncertain Evidence
Caveats: Both cited articles are undated; recency is uncertain. Support is weak and based on article context, not direct positive events. No material adverse evidence is available, but no strong current catalyst is validated either. |
| 89 | Modul8 lowweak | Opp 4 Risk 3 | Thesis: Risk remains moderate because the reviewed sources supplies no available positive evidence after recent evidence window to confirm timing, contract status, or deployment progress; mission-heavy lunar communications programs can be timing-sensitive, but these reviewed sources gives no adverse proof either. Why now: Among sparse names, the stated combination of funding plus lunar communications program exposure could matter over 1 year+, but recency cannot be validated from served evidence. Caveats: The strongest claims are only in membership rationale and not backed by citeable -bearing evidence in the reviewed sources. No negative evidence does not equal low fundamental risk. |
| 90 | Muon Space lowweak | Opp 3 Risk 3 | Thesis: Risk is balanced with opportunity because the available evidence is mostly weak supporting article context rather than direct contract, financing, or milestone evidence, leaving business traction and near-medium term scaling uncertain. Why now: The most recent dated context is a May 22, 2026 job posting indicating contracting and legal operations needs, which may imply organizational buildout but is weak evidence for a major catalyst. Evidence
Caveats: The reviewed sources contain no direct positive or negative company-specific events. The May 22, 2026 job posting is operational context, not proof of revenue or contracts. Citation |
| 91 | NordSpace Corp. lowweak | Opp 3 Risk 3 | Thesis: No direct adverse evidence is available, but development-stage rocket businesses carry obvious execution dependency; in these reviewed sources that risk cannot be upgraded to high because the evidence does not show a specific setback, only insufficient current confirmation. Why now: The only directional clue is the membership-support article reference: but the reviewed sources includes no, no summary, and no available post-recent evidence window evidence, so timing and durability are uncertain. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Opportunity case relies on generic funding support mention without current milestone evidence. |
| 92 | Northrop Grumman Corp mediumstrong | Opp 8 Risk 3 | Thesis: Risk is present but comparatively modest in the reviewed sources because no material adverse event is cited. The main risk is that the evidence is largely supporting article context and program participation, so exact economic contribution, timing, and competitive share are not fully established here. Why now: The setup is current and cumulative: April 8, 2026 Andromeda participation, June 1, 2026 Golden Dome interceptor partnership, and June 22, 2026 award of a $398M protected satcom contract all fall within the 90-day recent evidence window and point to sustained momentum. Evidence
Caveats: The reviewed sources does not provide direct business impact breakdowns beyond the $398M contract article. Some support is supporting article context rather than dated events. |
| 93 | NorthStar Earth & Space lowweak | Opp 4 Risk 3 | Thesis: Risk is moderate because evidence coverage is very thin, and the reviewed sources offers mainly context that the company planned to go public via SPAC, without stronger direct proof on operational milestones or contract conversion in this company row. Why now: The only dated evidence in this row is an April 27, 2026 article-level summary stating NorthStar Earth & Space plans to go public in a SPAC deal at a $300 million valuation. That may matter over a 1 year+ horizon, but the reviewed sources does not provide stronger company-specific direct evidence here. Evidence
Caveats: Coverage is extremely thin in this row: only one external article and no direct positive or negative dated events. The phase-2 rationale mentions a CAD$40M+ Royal Canadian Air Force contract, but that contract evidence is not directly surfaced in the available evidence fields for this output row, so it should not be elevated beyond the membership rationale. |
| 94 | Open Cosmos mediummedium | Opp 7 Risk 3 | Thesis: Risk is present but not strongly evidenced as negative news. The main risks are that the evidence is supporting article context rather than direct events, and one supporting item concerns spacecraft supply to a military mission rather than direct revenue or contract award to Open Cosmos. Why now: The timing is favorable for a 1 year+ horizon because the latest dated evidence on June 17, 2026 indicates market entry and operation of the first telecom satellites, which can matter over a multi-quarter rollout period. A prior April 8, 2026 article also shows Open Cosmos spacecraft being used in the Orpheus UK military mission, adding defense-adjacent relevance. These dates are source dates extracted from the article summaries. Evidence
Caveats: Evidence is external article context and weak-context rows, not direct positive events. Same-article repeated rows are not independent confirmation. |
| 95 | Orbital lowweak | Opp 4 Risk 3 | Thesis: Risk is also meaningful because the same article describes an early-stage startup with only a $5 million pre-seed raise pursuing an extremely ambitious plan involving an in-orbit demo next year and more than 100,000 orbital data centers, which raises execution and scale risk, although this is supporting article context rather than direct adverse evidence, June 10, 2026). Why now: The recency is relatively fresh: the is based on June 10, 2026, inside the 90-day recent evidence window, and it frames both new capital and a next-year demo as near-to-medium-term strategic milestones. Evidence
Caveats: All retained evidence is weak context supporting article context; there is no direct positive event/fact available. Same-article repeated rows are not independent confirmation. The opportunity case depends on an early-stage roadmap and financing announcement; commercial traction is not directly evidenced in retained rows. |
| 96 | Orbital Recovery Crew lowweak | Opp 3 Risk 3 | Thesis: Risk is also material because the evidence is limited to the company's own site and supporting article context, with no independent retained event evidence for contracts, missions, financing, customers, or regulatory outcomes; the same page also conditions service availability on manifest availability and continuing cooperation of regulatory bodies. Why now: The only retained evidence is a page with May 21, 2026, within the 90-day window, indicating recent discoverable claims of operations and service scope, but not a third-party validated catalyst. Evidence
Caveats: Evidence is company-site article context, not independent confirmation. No direct positive or negative dated events are available. Same-article repeated rows are not independent confirmation. |
| 97 | Overview Energy lowweak | Opp 4 Risk 3 | Thesis: The technology area appears highly ambitious and execution-sensitive, but no direct negative evidence is provided in the reviewed sources. Why now: The likely catalyst is the reported Air Force contract, yet the reviewed sources gives no retained article summary or evidence row to establish recency or contract scale. Caveats: Phase2 membership rationale references: but no article summary or evidence are available. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 98 | Pacific Defense lowweak | Opp 4 Risk 3 | Thesis: Despite the favorable context, the reviewed sources contain no post-recent evidence window evidence, no -backed article summary, and no fresh proof of follow-on contracts or operational success after the demo; that limits conviction and leaves execution risk unresolved. Why now: The company appears more advanced than several peers because the reviewed sources references an on-orbit demo under contract, but there is no citable recency signal beyond membership support article ID: and no available evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary for citation. Opportunity score is relative within a weak-evidence batch, not high absolute conviction. |
| 99 | Payload Aerospace, S.A. lowweak | Opp 2 Risk 3 | Thesis: Main risk is evidence opacity and recency uncertainty rather than documented adverse events. The reviewed sources show one article considered but zero article IDs after recent evidence window and zero evidence available after recent evidence window, so business-state visibility is poor. Why now: Why now is weak because the reviewed sources' coverage debug shows zero article IDs after the March 29, 2026 cutoff and zero evidence after recent evidence window; any older fundraising context may no longer capture current business state. See support references listing article in the membership rationale, but no or article detail is provided in the reviewed sources, so recency and context cannot be independently assessed. Caveats: No -bearing article detail is provided for the fundraising support article, so factual claims beyond the membership rationale cannot be expanded. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, limiting confidence. |
| 100 | Planet Labs PBC lowweak | Opp 3 Risk 3 | Thesis: Risk is moderate because the reviewed sources lack recent direct evidence on contracts, growth, financing, or setbacks, leaving the current business trajectory uncertain. Why now: Why-now is weak: the only in-window evidence is an April 5, 2026 startup-listing article describing Planet as operating its own satellite constellation and geospatial analytics platform, which is durable context but not a clear catalyst. Evidence
Caveats: Evidence is only supporting article context, not direct company event or fact evidence with strong materiality. No direct positive or negative dated events are available. This is a low-conviction watchlist name in these reviewed sources. |